Skip to content

Comparison between therapeotic effects of methylphenidate with rispredone in cristal dependent patients

Comparison between therapeotic effects of methylphenidate with rispredone in methamphetamin dependent patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201202159018N1
Enrollment
60
Registered
2012-04-16
Start date
2012-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

methamphetamin dependency. T43.6

Interventions

Intervention 1: standard group give rispredone1mg during 1week,than 1mg/bid during 3 week. Intervention 2: intervention group give methylphenidate10mg/day during 2week,than 7,5 mg/day during 1 week
Treatment - Drugs
standard group give rispredone1mg during 1week,than 1mg/bid during 3 week
intervention group give methylphenidate10mg/day during 2week,than 7,5 mg/day during 1 week ,than 5 mg/day during 1 week

Sponsors

Tavana clinic
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Methamphetamine dependence(More than 10 times the regular use of methamphetamine or 10 days); ;Positive Methamphetamine urien test ; Age 18-65 ; note dependency to other opioid and opium ; Exclusion : siezer;tardive dyskinesia or tic; gravidity;past history of methyl phenidate craving; past history of diabetes or MI;past history of allegy to rispredone; past history of suicide;under treatment by anti psychotic drug or mood stabilizer or inhibitor CYP2D6 drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Craving. Timepoint: befor and during and after invetervention. Method of measurement: psycological exam.;Sleep condition improve. Timepoint: befor and during and after invetervention. Method of measurement: Beck questionnaire.;Psycotic reaction. Timepoint: befor and during and after invetervention. Method of measurement: Beck questionnaire and psycological exam.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasti barzoki Akram

arak medicin univercity

fotroshozoor yahoo.com+98 86 1222 0224

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026